Search Results - "Bucko, Alicia D"

Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas by Bucko, Alicia D., Jarratt, Michael, Stough, Dowling B., Kyhl, Laerke, Villumsen, John, Hall, Anders

“…Purpose: Actinic keratoses (AKs) exist on a continuum with squamous cell carcinoma and can occur as sub-clinical and clinically visible lesions in cancerized…”
Get full text

Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study by Tschen, Eduardo H, Bucko, Alicia D, Oizumi, Norihide, Kawabata, Hideki, Olin, Jason T, Pillai, Radhakrishnan

“…Onychomycosis is a common nail infection that is difficult to treat successfully. The prevalence increases with age and is associated with diabetes. Oral…”
Get more information

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials by Stein Gold, Linda F, Jarratt, Michael T, Bucko, Alicia D, Grekin, Steven K, Berlin, Joshua M, Bukhalo, Michael, Weiss, Jonathan S, Berk, David R, Chang-Lin, Joan-En, Lin, Vince, Kaoukhov, Alexandre

“…Treatment of acne vulgaris (acne) with dapsone gel, 5% requires twice-daily dosing, and some patients may not adhere to this regimen. The objective of this…”
Get more information

Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections by Bucko, Alicia D., Hunt, Barbara J., Kidd, Sarah L., Hom, Richard

“…Background: Uncomplicated skin and skin-structure infections are commonly observed in medical practice. Because these infections typically are confined to the…”
Get full text

Fluorouracil cream 0.5% for the treatment of actinic keratoses on the face and anterior scalp: interim results of an 18-month open-label study by Stough, Dow, Bucko, Alicia D, Vamvakias, George, Rafal, Elyse S, Davis, Steven A

“…This study further assessed the long-term safety and efficacy of fluorouracil cream 0.5% in patients with multiple actinic keratosis (AK) on the face/anterior…”
Get full text

Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label Study by STOUGH, Dow, BUCKO, Alicia D, VAMVAKIAS, George, RAFAL, Elyse S, DAVIS, Steven A

“…This prospective 18-month, open-label, multicenter study assessed the long-term safety and efficacy of fluorouracil cream 0.5% in 277 participants with…”
Get full text

Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%-Tretinoin 0.025% : Results From a 52-Week Open-Label Study by KIRCIK, Leon H, PEREDO, Marina I, BUCKO, Alicia D, LOSS, Robert W, FOWLER, Joseph F, WORTZMAN, Mitchell, NEUMAIER, George J

“…Acne affects as many as 50 million individuals in the United States. Topical therapy combining a retinoid and an antibiotic is recommended as a first-line…”
Get full text

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial by Monroe, Eugene, Finn, Albert, Patel, Piyush, Guerrero, Robinson, Ratner, Paul, Bernstein, David

“…Background: Chronic idiopathic urticaria (CIU) has a major impact on patient well-being. Antihistamines are the first-line treatment for CIU; however, some…”
Get full text

Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study by Thiboutot, Diane M., MD, Weiss, Jonathan, MD, Bucko, Alicia, DO, Eichenfield, Lawrence, MD, Jones, Terry, MD, Clark, Scott, MD, Liu, Yin, PhD, Graeber, Michael, MD, Kang, Sewon, MD

“…Background A fixed-dose combination gel with adapalene 0.1% and benzoyl peroxide (BPO) 2.5% has been developed for the once-daily treatment of acne. Objective…”
Get full text

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail by Scher, Richard K., Breneman, Debra, Rich, Phoebe, Savin, Ronald C., Feingold, David Stuart, Konnikov, Nellie, Shupack, Jerome L., Pinnell, Sheldon, Levine, Norman, Lowe, Nicholas J., Aly, Raza, Odom, Richard B., Greer, Donald L., Morman, Manuel R., Bucko, Alicia D., Tschen, Eduardo H., Elewski, Boni E., Smith, Edgar B.

“…Background: Onychomycosis is a prevalent infection of the nail caused primarily by dermatophytes. Fluconazole is active in vitro against the most common…”
Get full text

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail by Drake, Lynn, Babel, Dennis, Stewart, Daniel M., Rich, Phoebe, Ling, Mark R., Breneman, Debra, Scher, Richard K., Martin, Ann G., Pariser, David M., Pariser, Robert J., Ellis, Charles N., Kang, Sewon, Katz, Harry Irving, McDonald, Charles J., Muglia, Jennie, Savin, Ronald C., Webster, Guy, Elewski, Boni E., Leyden, James J., Bucko, Alicia D., Tschen, Eduardo H., Hanifin, Jon M., Morman, Manuel R., Shupack, Jerome L., Levine, Norman, Lowe, Nicholas J., Bergfeld, Wilma F., Camisa, Charles, Feingold, David Stuart, Konnikov, Nellie, Odom, Richard B., Aly, Raza, Greer, Donald L.

“…Background: Onychomycosis is a prevalent infection of the nail caused primarily by dermatophytes. Fluconazole is active in vitro against the most common…”
Get full text

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail by Rich, Phoebe, Scher, Richard K., Breneman, Debra, Savin, Ronald C., Feingold, David Stuart, Konnikov, Nellie, Shupack, Jerome L., Pinnell, Sheldon, Levine, Norman, Lowe, Nicholas J., Aly, Raza, Odom, Richard B., Greer, Donald L., Morman, Manuel R., Bucko, Alicia D., Tschen, Eduardo H., Elewski, Boni E., Smith, Edgar B., Hilbert, James

“…Background: Preliminary clinical data suggest that fluconazole is effective in the treatment of patients with onychomycosis. To design optimum dosage regimens,…”
Get full text

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail by Savin, Ronald C., Drake, Lynn, Babel, Dennis, Stewart, Daniel M., Rich, Phoebe, Ling, Mark R., Breneman, Debra, Scher, Richard K., Martin, Ann G., Pariser, David M., Pariser, Robert J., Ellis, Charles N., Kang, Sewon, Friedman, David, Katz, Harry Irving, McDonald, Charles J., Muglia, Jennie, Webster, Guy, Elewski, Boni E., Leyden, James J., Bucko, Alicia D., Tschen, Eduardo H., Hanifin, Jon M., Morman, Manuel R., Shupack, Jerome L., Levine, Norman, Lowe, Nicholas J., Bergfeld, Wilma F., Camisa, Charles, Feingold, David Stuart, Konnikov, Nellie, Odom, Richard B., Aly, Raza, Greer, Donald L., Hilbert, James

“…Background: Fluconazole has proven to be safe and effective for a variety of superficial and systemic fungal infections. Preliminary analysis of extensive…”
Get full text

Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema by Tschen, E H, Bucko, A D

“…This study evaluated the effects of fluticasone cream 0.05% on the hypothalamopituitary-adrenal (HPA) axis in patients with extensive psoriasis or eczema. Six…”
Get full text